发明名称 OCULAR COMPOSITION AND METHOD
摘要 An ocular composition can include a polymer matrix and an antibiotic dispersed in the polymer matrix. The polymer matrix can contain a thiolated hyaluronic acid moiety cross-linked to a second moiety. The composition can be configured for placement in or on an eye of a subject to provide controlled release of the antibiotic to the eye. A method of treating or preventing an ocular disease can include providing an ocular composition and applying the ocular composition to a surface of an eye of a subject to provide controlled release of the antibiotic to the eye. The ocular composition can include a polymer matrix and an antibiotic dispersed in the polymer matrix. The polymer matrix can include a thiolated hyaluronic acid moiety cross-linked to a second moiety.
申请公布号 US2015157563(A1) 申请公布日期 2015.06.11
申请号 US201414584787 申请日期 2014.12.29
申请人 Jade Therapeutics, Inc 发明人 Wirostko Barbara
分类号 A61K9/00;A61K9/70;A61K45/06;A61K31/7036;A61K31/407;A61K31/522;A61K31/5575;A61K31/4709;A61K47/36 主分类号 A61K9/00
代理机构 代理人
主权项 1. An ocular composition, comprising: a polymer matrix comprising a thiolated hyaluronic acid moiety cross-linked to a second moiety; and an antimicrobial dispersed in the polymer matrix at a dosage sufficient to inhibit microbial growth; wherein the composition is configured for placement in or on an eye of a subject, and wherein the composition provides controlled release of an amount of the antimicrobial to the eye.
地址 Salt Lake City UT US